Absinthe, epileptic seizures and Valentin Magnan

Journal of the Royal College of Physicians of Edinburgh

Volumn 39, Issue 1, 2009, Pages 73-78

  Eadie, M J ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b NONE   (Australia)

Author keywords

Absinthe; Epilepsy; Magnan; Thujone; Wormwood

Indexed keywords

ABSINTHOL; ARTEMISIA ABSINTHIUM EXTRACT; OXAZOLIDINEDIONE DERIVATIVE; PENTETRAZOLE; PICROTOXININ;

ABSINTHE; ALCOHOL CONSUMPTION; ARTICLE; CLINICAL RESEARCH; COMA; DRUG MEGADOSE; DRUG STRUCTURE; EPILEPSY; EPILEPTOGENESIS; FRANCE; HUMAN; LOW DRUG DOSE; MENTAL DISEASE; NEUROTOXICITY; NONHUMAN; PARAPLEGIA; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; PETIT MAL; PHYSICIAN; PUBLICATION; SEIZURE; TONIC CLONIC SEIZURE;

ABSINTHE; ARTEMISIA; EPILEPSY; FRANCE; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; MONOTERPENES;

EID: 70349635577     PISSN: 14782715     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. The Papyrus Ebers. The greatest Egyptian medical document. Translated by Ebbell B. Copenhagen: Levin & Munksgaard; I937. 1b Pliny. Natural history. Translated by Jones WHS. London and Cambridge, Mass: Heinemann and Harvard University Press; 1951.
2. Günther RT, editor. The Greek herbal of Dioscorides. New York: Hafner; 1959.
3. Adams J. Hideous absinthe. A history of the devil in a bottle. London and New York: Tauris; 2004.
4. Padosch SA, Lachenmeier DW, Kröner LU. Absinthism: a fictitious 19th century syndrome with present impact. Subst Abuse Treat Prev Policy 2006; 1(1):14.
5. Lachenmeier DW, Walch SG, Padosch SA et al. Absinthe - a review. Crit Rev Food Sci Nutr 2006; 46(5):365-77.
6. European Commission. Opinion of the Scientific Committee on Food on thujone. Brussels: European Commission; 2003. Available from: http://ec.europa.eu/food/fs/sc/scf/out162_en.pdf
7. Anonymous. Absinthe and alcohol. Lancet 1869; i:334.
8. Strang J, Arnold WN, Peters T. Absinthe: what's your poison? Though absinthe is intriguing, it is alcohol in general we should worry about. BMJ 1999; 319(7225):1590-2.
9. Lachenmeier DW, Emmert J, Kuballa T et al. Thujone - cause of absinthism? Forensic Sci Int 2006; 158(1):1-8.
10. Hutton I. Myth, reality and absinthe. Curr Drug Discov 2002; 9:62-4.
11. Luauté J-P. L'absinthisme: la faute du docteur Magnan. L'évolution psychiatrique 2007; 72:515-30.
12. Dowbiggin I. Back to the future: Valentin Magnan, French psychiatry, and the classification of mental disease, 1885-1925. Soc Hist Med 1996; 9(3):353-408.
13. Shorter E. A history of psychiatry. New York: Wiley; 1997.
14. Motet A. Considerations générales sur l'alcoolisme, et plus particularément des effets toxiques products sur l'homme par la liqueur d'absinthe [Thesis]. Paris: University of Paris; 1859.
15. Marcé M. Sur l'action toxique de l'essence d'absinthe. Comptes Rendus Hebdomadaires des Seances de l'Acadamie des Sciences 1864; 58:628-9.
16. Trousseau A. Lectures on clinical medicine. Vol. 1. Translated by Basire V. London: New Sydenham Society; 1868.
17. Magnan V. Accidents determines pat l'abus de la liqueur d'absinthe. L'union médicale 1864; 92:227-32, 94:257-62.
18. Magnan V. Epilepsie alcoolique; action spéciale de l'absinthe: épilepsie absinthique. C R Biol 1869; 20:156-61.
19. Magnan V. Étude expérimentale et clinique sur l'alcoolisme. Alcool et absinthe. Epilepsie absinthique. Paris: Renou et Maulde; 1871.
20. Magnan V. Recherche de physiologie pathologique avec l'alcool et l'essence d'absinthe. Arch Physiol Norm Patho 1873; 5:115-42.
21. Magnan V. De l'alcoolisme, des diverses formes de délire alcoolique et de leur traitment. Paris: Delahaye; 1874.
22. Magnan V. On the comparative action of alcohol and absinthe. Lancet 1874; 2:410-2.
23. Amory R. Experiments and observations on absinth and absinthism. Boston Med Surg J 1868; 1:68-71, 83-5.
24. Herpin T. Des accès incomplets d'épilepsie. Paris: Ballière; 1867.
25. Höld KM, Sirisoma NS, Ikeda T et al. α-Thujone (the active component of absinthe): γ-aminobutyric acid type A receptor modulation and metabolic detoxication. Proc Nat Acad Sci 2000; 97:3826-31.
26. Del Castillo J, Anderson M, Rubottom GM. Marijuana, absinthe and the central nervous system. Nature 1975; 253:365-6.
27. Meschler JP, Howlett AC. Thujone exhibits low affinity for cannabinoid receptors but fails to evoke cannabimimetic responses. Pharmacol Biochem Behav 1999; 62: 473-80.
28. Bonkovsky HL, Cable EE, Cable JW et al. Porphyrogenic properties of the terpenes camphor, pinene, and thujone. Biochem Pharmacol 1992; 43:2359-68.
29. Olsen RW. Absinthe and the gamma-aminobutyric acid receptors. Proc Nat Acad Sci 2000; 97:4417-8.
30. Grollman A, Grollman EF. Pharmacology and therapeutics. 6th ed. Philadelphia: Lea & Febiger; 1965.
31. Francois-Frank CE, Pitres A. Recherches expérimentales et critiques sur les convulsions épileptiformes d'origine corticale. Arch Physiol Norm Pathol 1883: 15:1-40, 101-44.
32. Horsley V. Production of artificial epilepsy in guinea-pigs. BMJ 1886; 2:976-7.
33. Dupuy E. The rolandic area cortex. Brain 1892; 15:190-214.
34. Ott I. The seat of absinthic epilepsy. J Nerv Ment Dis 1892;19:696-8.
35. Boyce R. A contribution to the study of descending degenerations in the brain and spinal cord, and of the seat of origin and paths of conduction of the fits of absinthe epilepsy. Phil Trans 1895;189:321-81.
36. Florey H. Microscopical observations on the circulation of the blood in the cerebral cortex. Brain 1925; 48:43-64.
37. Culpeper N. The complete herbal and the English physician enlarged. Ware: Wordsworth Editions; 1995 (Originally published 1653).
38. Lennox WG. Bernard of Gordon on epilepsy. Ann Med Hist 1941; 3:372-83.
39. North J. Practical observations on the convulsions of infants. London: Burgess & Hill; 1826.
40. Osler W. The principles and practice of medicine. New York: Appleton & Co.;1892.
41. Gowers WR. Epilepsy and other chronic convulsive diseases: their causes, symptoms and treatment. London: Churchill; 1881.
42. Hill J. The family herbal. Bungay: Brightly & Co; 1812.